Log in to save to my catalogue

Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy tha...

Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy tha...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68576163

Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig

About this item

Full title

Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig

Publisher

United States: Elsevier Limited

Journal title

Molecular therapy, 2006-07, Vol.14 (1), p.5-13

Language

English

Formats

Publication information

Publisher

United States: Elsevier Limited

More information

Scope and Contents

Contents

Although gene therapy has reduced manifestations of genetic diseases, immune responses can abrogate the effect. One approach to inducing tolerance is to perform gene transfer in newborns when the immune system is immature. We demonstrate here that the dose of retroviral vector (RV) is important in mice, as mucopolysaccharidosis I (MPS I) mice that...

Alternative Titles

Full title

Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68576163

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68576163

Other Identifiers

ISSN

1525-0016

E-ISSN

1525-0024

DOI

10.1016/j.ymthe.2006.03.015

How to access this item